Reference Source

Merck Sharp & Dohme · 66-66 · FRANCE

For Merck Sharp & Dohme · 66-66 · FRANCE, import alert is 66-66; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; country is FRANCE; product is Imipenem; product code is 64 U - S 04 Cilastatin Sodium/Imipenem (Inhibitor (Decarboxylase)), Active Pharm Ingred/Chems for Further Manuf; date published is 09/30/2009; address is 3 Avenue Hoche , BP 134 , Paris, FRANCE, verified against its source on 2026-09-16.

Firm
Merck Sharp & Dohme verified
Import alert
66-66
Import alert name
"APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
Country
FRANCE verified
Address
3 Avenue Hoche , BP 134 , Paris, FRANCE verified
Date published
09/30/2009 verified
Product code
64 U - S 04 Cilastatin Sodium/Imipenem (Inhibitor (Decarboxylase)), Active Pharm Ingred/Chems for Further Manuf verified
Product
Imipenem verified
FDA notes
11/2/2000 verified
Sourceaccessdata.fda.gov
Verified
Review by
DatasetFDA import alert red lists: firms subject to detention without physical examination

What the source says

Merck Sharp & Dohme Date Published : 09/30/2009 3 Avenue Hoche , BP 134 , Paris, FRANCE 64 U - S 04 Cilastatin Sodium/Imipenem (Inhibitor (Decarboxylase)), Active Pharm Ingred/Chems for Further Manuf Date Published: 04/02/2019 Desc: Imipenem Notes: 11/2/2000

accessdata.fda.gov, retrieved 2026-09-15

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.

This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.